A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized ...

A groundbreaking new clinical trial has found that taking a low dose of the common fever medicine Aspirin halves the risk of ...

Among adults with chronic rhinosinusitis with nasal polyps, asthma and NSAID-exacerbated respiratory disease, aspirin after desensitization does not benefit most patients vs. placebo, according to ...

The painkilling, antipyretic, and antiinflammatory properties of aspirin have been known for centuries. The understanding that aspirin targets cyclooxygenase-1 (COX-1) (also known as ...

A major trial reveals that a daily aspirin dose can significantly reduce the risk of certain colorectal cancers returning post-surgery.

A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical trial that a low dose of the well-known medicine aspirin halves the risk ...

Scientists have demonstrated that a common blood thinner is more effective than aspirin—and just as safe—for patients with ...

Aspire’s sublingual aspirin formulation significantly inhibited serum thromboxane B2 (TxB2) within the first two minutes ...

Cardiovascular diseases, represented by myocardial infarction and cerebral infarction, are primarily caused by narrowed arteries and blood clots (thrombi) that block blood flow. Aspirin is known as a ...

Results presented at the Musculoskeletal Infection Society Annual Meeting showed use of aspirin was associated with decreased ...

A randomized placebo-controlled Finnish study showed that aspirin therapy does not provide significant relief for people ...